Report on how AI is redefining market landscape - The global microbiomes market size is estimated to grow by USD 1.13 billion from 2024-2028, according to Technavio. The market is estimated to grow at ...
When Anne Maldzinski underwent a blood stem-cell transplant to cure her cancer, the procedure triggered a life-threatening ...
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...
Although more evidence is needed, probiotics may help your immune system by creating and maintaining a healthy gut microbiome ...
Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...
Idorsia’s pipeline includes various drugs for the treatment of fabry disease, pediatric insomnia, demyelinating diseases, rare lysosomal storage disorders, recent-onset type 1diabetes, immune-mediated ...
Clostridium difficile infection (CDI) is considered to be the main cause of bacterial infectious diarrhea in nosocomial settings. Since the beginning of the new century a continuous rise in the ...
For a potential Phase 3 study, Shibutani noted the objective would be to discern the potential to reduce the severity of a C. diff infection (CDI) instead of aiming to reduce the risk and ...
Risks of colonoscopy include sedation risk, bleeding, infection and colonic perforation, which is increased if the patient exhibits signs of toxic colitis. [4] Treatment with enemas may be ...
Background: Intestinal parasitic infections continue to pose a major threat to human health globally, with a particularly high prevalence in developing countries. Soil-borne helminthiasis and ...